Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideIDXXIdexx Laboratories
FinDog View：Neutral
JNJJohnson & Johnson
FinDog View：Bullish
| Metric | IDXX | JNJ |
|---|
| Close | 513.62 | 267.28 |
| Market Cap | $40.5B | $644B |
| 1M | −5.95% | +1.87% |
| P/E (TTM) | 35.5 | 30.6 |
| Forward P/E | 35.6 | 20.7 |
| P/E 5-Yr Percentile | 0 | 90 |
| P/S | 8.9 | 6.6 |
| P/B | 25.1 | 7.6 |
| Dividend Yield | — | 3.12% |
| Latest Quarter Revenue | $1.2B | $25.3B |
| Revenue YoY | +9.7% | +6.6% |
| Gross Margin | 64.0% | 68.2% |
| Latest Quarter EPS | 4.27 | 2.27 |
| Avg Post-Earnings Move | ±1.8% | ±0.6% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | 1.25% |
| 90-Day Net Insider Buying | −$1.2M | −$67.8M |
IDXX · Revenue, Last 8 Quarters ($B)
JNJ · Revenue, Last 8 Quarters ($B)
